Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions
Molecular Pharmaceutics · 02.10.2023 · 20 (10) · 4802-4825
DOI: 10.1021/acs.molpharmaceut.3c00526 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 12.09.2023. Verfasst von Dana E Moseson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States. Hauptthemen laut MEDLINE: Solubility. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 201 Literaturangaben. Gefördert von: Division of Graduate Education.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States.
- Worldwide Research and Development Pfizer, Inc., Groton, Connecticut 06340, United States.
ORCID-Profile: Dana E Moseson, Lynne S Taylor
Förderung
- Division of Graduate Education
Zitieren
APA
Moseson, D. E., & Taylor, L. S. (2023). Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions. Molecular Pharmaceutics, 20(10), 4802-4825. https://doi.org/10.1021/acs.molpharmaceut.3c00526
Vancouver
Moseson DE, Taylor LS. Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions. Molecular Pharmaceutics. 2023;20(10):4802-4825. doi:10.1021/acs.molpharmaceut.3c00526
BibTeX
@article{Moseson2023,
author = {Moseson, Dana E and Taylor, Lynne S},
title = {Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions},
journal = {Molecular Pharmaceutics},
year = {2023},
volume = {20},
number = {10},
pages = {4802--4825},
doi = {10.1021/acs.molpharmaceut.3c00526}
}
EUVIMED